BridgeBio Pharma, Inc. - COM (BBIO)

Historical Portfolio Holders from Q2 2019 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
169 M
Holdings value Q1 2024
$5.22 B
Value change Q1 2024
+$127 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
229
Number of buys Q1 2024
129
Number of sells Q1 2024
-121
Average buys Q1 2024 %
+0.003%
Average sells Q1 2024 %
-0.003%
CUSIP
10806X102
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 169 M $5.22 B +$127 M $30.92 229
2023 Q4 163 M $6.57 B +$98.9 M $40.37 247
2023 Q3 160 M $4.21 B +$311 M $26.37 218
2023 Q2 148 M $2.55 B -$53.8 M $17.20 201
2023 Q1 152 M $2.52 B +$153 M $16.58 216
2022 Q4 144 M $1.1 B -$14.6 M $7.62 172
2022 Q3 145 M $1.44 B +$49 M $9.94 169
2022 Q2 138 M $1.25 B -$25.4 M $9.08 150
2022 Q1 141 M $1.43 B -$30.3 M $10.15 162
2021 Q4 141 M $2.35 B -$120 M $16.68 189
2021 Q3 140 M $6.55 B -$165 M $46.87 206
2021 Q2 142 M $8.67 B +$97.1 M $60.96 197
2021 Q1 141 M $8.68 B +$1.24 B $61.60 196
2020 Q4 121 M $8.58 B +$180 M $71.11 161
2020 Q3 118 M $4.39 B +$21.7 M $37.52 124
2020 Q2 117 M $3.82 B +$146 M $32.61 114
2020 Q1 113 M $3.27 B +$163 M $29.00 89
2019 Q4 99.9 M $3.5 B +$148 M $35.05 81
2019 Q3 103 M $2.22 B +$110 M $21.47 71
2019 Q2 99.9 M $2.7 B +$2.7 B $26.97 60